Sanofi-Aventis Appoints Euro RSCG Worldwide, Part of the Havas Group, as one of its two Strategic Communication Partners, and now Becomes one of Havas' top Three Clients Euro RSCG Will Manage all Communication Activity for New Diabetes and

Thrombosis Therapy Brands Through its Euro RSCG Life Global Healthcare

Agency Group

Euro RSCG C&O Wins the Corporate Communications Account



    PARIS, November 16 /PRNewswire-FirstCall/ -- Sanofi-Aventis, a leading
 pharmaceutical company headquartered in France, has confirmed Euro RSCG
 Life as the global agency in charge of all communications for
 Lovenox/Clexane, the no 1 product for thrombosis treatment, and for Lantus
 and Apidra, market leading diabetes treatments. Sanofi-Aventis has also
 amplified its partnership with Euro RSCG Life by awarding the agency the
 responsibility of launching all communications programs for all new brands
 in these two therapeutic domains.
     Sanofi-Aventis has also awarded Euro RSCG C&O their Corporate
 Communications account, including internal editorial programs and
 publications.
     The Havas Group emphasizes that this success is the fruit of real
 international collaboration with all Euro RSCG Worldwide's teams in more
 than 40 countries.
     Sanofi-Aventis is Euro RSCG Worldwide's first global pharmaceutical
 client and this appointment demonstrates a significant increase in activity
 across the broad range of skills offered by Euro RSCG Worldwide-
 advertising, corporate communications, media relations, medical
 communication and interactive communication.
     About Havas
     Havas (Euronext Paris: HAV.PA) is a global advertising and
 communications services group. Headquartered in Paris, Havas operates
 through its two worldwide networks, Euro RSCG Worldwide headquartered in
 New York and Havas Media in Barcelona, and through Arnold Worldwide
 Partners. A multicultural and decentralized Group, Havas is present in more
 than 75 countries through its networks of agencies and contractual
 affiliations. The Group offers a broad range of communications services,
 including traditional advertising, direct marketing, media planning and
 buying, corporate communications, sales promotion, design, human resources,
 sports marketing, multimedia interactive communications and public
 relations. Havas employs approximately 14,400 people.
     Further information about Havas is available on the company's website:
 www.havas.com
     About Sanofi-Aventis
     The Sanofi-aventis Group is the world's 3rd largest pharmaceutical
 company, ranking number 1 in Europe. Backed by a world-class R&D
 organization, Sanofi-Aventis is developing leading positions in seven major
 therapeutic areas: cardiovascular disease, thrombosis, oncology, diabetes,
 central nervous system, internal medicine, vaccines.
     Contacts:
 
     Havas: Anne Marsan
     Tel: +33(0)1-58-47-90-33
     anne.marsan@havas.com
 
     Solenne Anthonioz
     Tel: +33(0)1-58-47-90-27
     solenne.anthonioz@havas.com
 
     Euro RSCG Worldwide: Jonathan Sanchez
     Tel: +1-646-206-46-53
     jonathan.sanchez@eurorscg.com
 
 

SOURCE Havas

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.